The Syneos Health Podcast

Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals

April 17, 2019
The Syneos Health Podcast
Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals
Chapters
The Syneos Health Podcast
Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals
Apr 17, 2019
Jeffrey Stewart / Amy Hutnik
Show Notes

The art of communications in the pharmaceutical industry is becoming more complex.

According to Amy Hutnik, Chief Growth and Transformation Officer for Syneos Health Communications, we’ve evolved from the point of DTC (Direct to Consumer) to the extremely individualized opportunity of DT“Me” (Direct to Me).  The landscape has changed dramatically in terms of not only the sheer number of channels available to us for communicating with our audience, but also in the data available to provide the insights we need to make decisions about how, when and how much we spend on our promotional activities.

Listen in for a discussion on the way the space has changed in terms of decision-making and spend/budget planning, the necessity for breaking down the silos in large companies, why (despite popular belief) personal promotion is not dead – and a look at what lies ahead in the future of communications in pharmaceuticals.

Like what you hear?  Please be sure to subscribe, rate and review us!